Nomura Holdings
PVLA

Nomura Holdings’s Palvella Therapeutics PVLA Stock Holding History

Nomura Holdings’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.66M Sell
23,963
-45
-0.2% -$5.46K ﹤0.01% 891
2026
Q1 		$2.99M Buy
+24,008
New +$2.5M 0.01% 796
2016
Q1 		– Sell
-138
Closed -$25K – 2072
2015
Q4 		$25K Buy
+138
New +$23.2K ﹤0.01% 1794

Other funds holding PVLA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Nomura Holdings's PVLA Position: Q2 2026 in Review

Nomura Holdings reduced its Palvella Therapeutics (PVLA) stake by 0.19% in Q2 2026, selling an estimated $5.46K and leaving 23,963 shares worth $3.66M. The position accounts for ﹤0.01% of the portfolio, ranked #891.

Nomura Holdings first reported a position in PVLA in Q4 2015 and has held it in 3 quarters since. 181 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

  • Nomura Holdings held 23,963 shares of Palvella Therapeutics worth $3.66M as of Q2 2026.
  • Nomura Holdings sold 45 Palvella Therapeutics shares in Q2 2026, an estimated $5.46K.
  • Palvella Therapeutics made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #891 holding.
  • Nomura Holdings first reported a position in Palvella Therapeutics in Q4 2015 and has held it in 3 quarters since.
  • 181 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.